1A: PANEL: The Synergy of Science and Medicine in Advancing CMS Objectives: Translating Biomaterials into Market-Ready Regenerative Devices

Date: Wednesday, March 25, 2026
Time: 1:30 PM to 3:30 PM
Room: Centennial III/IV
Session Type: Concurrent Session 1

Description

A significant barrier to the successful commercialization of medical devices lies in the limited understanding of market valuation, supply chain management, and Medicare reimbursement. Biomaterials scientists should play a more prominent role, alongside clinicians, in shaping regulatory policies to ensure fair and accurate valuation. Without their expertise, there is a substantial risk of device mispricing, which can limit both their clinical impact and the broader influence of the biomaterials field.

To strengthen our professional community and elevate the standing of our organization, it is essential for scientists to actively engage in the commercial and regulatory landscape.
This objective will be addressed through an open panel discussion aimed at identifying and analyzing key challenges faced by developers of biomaterial-based medical devices. A particular focus will be on the difficulty of conveying advanced scientific information to payers such as the CMS, which currently rely predominantly on clinical input, with minimal involvement from biomaterials scientists.

Moderators:

Dr. Subramanian Gunasekaran
BMPC SIG, SFB
President, Encoll Corp

Murugan Gunasekaran
VP Sales & Marketing
Encoll Corp

  • Talk by Joe Rolley, JTR Business Consulting, LLC Open Talk by Joe Rolley, JTR Business Consulting, LLC configuration optionsEditDelete Speakers Joe Rolley

  • Talk by Murugan Gunasekaran, Encoll Corp. Open Talk by Murugan Gunasekaran, Encoll Corp. configuration optionsEditDelete Speakers Murugan Gunasekaran

  • Talk by Subramanian Gunasekaran, Encoll Corp. Open Talk by Subramanian Gunasekaran, Encoll Corp. configuration optionsEditDelete Speakers Dr. Subramanian Gunasekaran

  • Talk by Traci Kimball, The Wish Clinic Open Talk by Traci Kimball, The Wish Clinic configuration optionsEditDelete Speakers Dr. Traci Kimball

1B: Biomaterial-Based Therapies for Osteoarthritis and Skeletal Repair

Date: Wednesday, March 25, 2026
Time: 1:30 PM to 3:30 PM
Room: Centennial I
Session Type: Concurrent Session 1

Description

Musculoskeletal diseases are among the leading causes of disability worldwide, significantly impairing mobility, function, and quality of life. Among them, osteoarthritis (OA) is the most prevalent degenerative joint disorder, affecting nearly 15% of the global population and imposing an escalating socioeconomic burden. Despite its widespread impact, no curative or disease-modifying treatments currently exist. As aging populations expand and joint injuries become more common, the need for innovative regenerative and therapeutic strategies is increasingly urgent.

This session will highlight advanced biomaterials-based approaches designed to move beyond symptomatic relief toward disease-modifying and restorative solutions for osteoarthritis and skeletal repair. Topics will include intra-articular drug delivery systems for sustained and localized therapeutic release, nanotechnology-enabled targeted therapies, bioengineered joint lubricants, immunomodulatory and cell-based therapies, and regenerative strategies for cartilage and bone restoration. This symposium will integrate synthetic and biologically inspired materials, smart and surface-modified systems, tissue engineering approaches, to advance the restoration and functional regeneration of musculoskeletal and craniofacial tissues.

Moderators:

Dr. Silviya Zustiak
Professor and Associate Chair; Co-Director, Institute of Drug and Biotherapeutic Innovation
Saint Louis University

Katherine Hixon
Assistant Professor of Engineering
Clinical Assistant Professor of Orthopaedics
Dartmouth

Era Jain
Assistant Professor
Biomedical and Chemical Engineering
Syracuse University

Christine Knabe
Philipps University Marburg

  • 2:00 PM. 6. Effect of bioactive resorbable calcium-alkali-orthophosphate bone substitute cements on osteogenesis and bone regeneration of critical-size femoral defects in rabbits.Christine Knabe, PhD, DDS, DMD1, Georg Berger, PhD2, Renate Gildenhaar, PhD2, Alireza Houshmand, PhD, DDS, MD1, Christian Müller-Mai, PhD, MD3, Alina Bednarek, PhD, DDS1, Christian Koch, PhD, DVM1, Daniela Joern, MSc2, Michael Stiller, PhD, DDS, MD1 1Philipps-University Marburg, 2Federal Institute for Materials Research and Testing, 3Hopital for Special Surgery Luenen
  • 2:15 PM. 7. Inclusion of 3D-printed hyperelastic bone mesh to improve osteogenic performance of mineralized collagen scaffold for bone repair.Alison Nunes1, Génesis Ríos Adorno1, Sam Christoff1, Jon Burke, M.Eng2, Ramille Shah, PhD2, Brendan Harley3 1University of Illinois at Urbana - Champaign, 2Dimension Bio, 3University of Illinois at Urbana Champaign
  • 2:30 PM. 8. Investigating the Diffusion Behavior of Dextran Derivates as Intra-Articular Injectable Biomaterials for Osteoarthritis.Jun Zhou1, Yasaman Aghli1, Treena Livingston Arinzeh, PhD1 1Columbia University
  • 2:45 PM. 9. Implantable Pressure Sensor with Biodegradability and Single-ended Configuration for Post-Surgical Joint Loading Monitoring.Jinyoung Park, M.Sc.1, Thanh Nguyen, Ph.D.1 1University of Connecticut
  • 3:00 PM. 10. Injectable Thermogel for Prolonged Joint Retention of Nanocarriers Loaded with Sirt6 Activators in Post-Traumatic Osteoarthritis.Zachary Varrenti1, Yiting Song1, Jacqueline Shine2, Mingqian He2, Jayishnu Roy1, Brian Diekman2, Jonathan Lovell1, Ramkumar Annamalai1 1University at Buffalo, 2The University of North Carolina at Chapel Hill
  • 3:15 PM. 11. Microfracture Clot-Penetrating Hyaluronic Acid Hydrogel Promotes Specific and Volumetric Cartilage Repair.Alan Zhao1, Hanna Solomon, B.S.1, Maddie Hasson, B.S.2, Samir Chihab1, Aniya Hartzler, B.S.1, Colleen Oliver, D.V.M.1, Robert Mauck, PhD2, Jason Bariteau, MD1, Jay Patel, Ph.D.1 1Emory University, 2University of Pennsylvania

  • Talk by Dr. Andres Garcia, Georgia Institute of Technology. Speakers Leslie Chan

1C: Biomaterials for In Vitro Models of Disease 1

Date: Wednesday, March 25, 2026
Time: 1:30 PM to 3:30 PM
Session Type: Concurrent Session 1

Description

Moderators:

Taimoor Qazi
Assistant Professor of Biomedical Engineering
Purdue University

Samantha Zambuto
Assistant Professor
Stanley and Karen Pigman College of Engineering
University of Kentucky

  • 1:30 PM. 12. Long-Term Adipocyte Spheroid Model to Recapitulate In Vivo–Like Insulin Resistance.Sheetal Chowdhury1, Gene Bidwell, PhD1, Joshua Speed, PhD1, Amol Janorkar, PhD1 1University of Mississippi Medical Center
  • 1:45 PM. 13. Engineered Tissue Model of CMS4 Colorectal Cancer Using Patient-derived Xenograft Tumor Cells.Kwaghtaver Desongu1, Elham Seyyedi Zadeh1, Ifeoluwa Odeniyi, PhD1, Kathryn McCloud, B.Sc1, Jannatul Nipa, M.Sc1, Camp Jernigan, B.Sc1, Michael . Greene, PhD1, Elizabeth Lipke1 1Auburn University
  • 2:00 PM. 14. Engineering pulmonary microtissues to investigate focal adhesion kinase-mediated tissue remodeling.Elisa Nieves1, Anish Vasan2, Louise Hecker, Dr.3, Jeroen Eyckmans, Dr.2, Andrés García, PhD1 1Georgia Institute of Technology, 2Boston University, 3Medicine - Cardiovascular Research
  • 2:15 PM. 15. Modeling insulitis in type 1 diabetes using synthetic hydrogels.Aliyah Tate1, Matthew Brown1, Magdalena Samojlik1, Cherie Stabler1, Todd Brusko1, Edward Phelps1 1University of Florida
  • 2:30 PM. 16. Ex Vivo Bone Marrow Subniches Influence the Fate of Human Antibody-Secreting Cells.Liana Kramer1, Zhonghai Dai1, Krishnendu Roy, Ph.D.2, Ankur Singh1 1Georgia Institute of Technology, 2Vanderbilt University
  • 2:45 PM. 17. Biochemical and Biophysical Regulation of Natural Killer Cell Infiltration Using a Tunable Hydrogel Model.Suzanne Lightsey1, Rylee Newport1, Gabriella Flinn1, Madison Temples, PhD1, Blanka Sharma, PhD1 1University of Florida
  • 3:00 PM. 18. Matrix Microarchitecture Drives Cellular Function and Extracellular Vesicle Proteome in Engineered Tendon Models.Kariman Shama, BS1, Zachary Greenberg, MS1, Mei He, PhD1, Brittany Taylor, PhD1 1University of Florida
  • 3:15 PM. 19. Screening salivary gland-acting drugs to control oral biofilm virulence via the salivary gland mimetic tissue chip.Sydney Yang, PhD1, Lisa DeLouise, PhD, MPD2, Danielle Benoit1 1University of Oregon, 2University of Rochester

1D: Advances in Dynamic Crosslinking of Hydrogels

Date: Wednesday, March 25, 2026
Time: 1:30 PM to 3:30 PM
Room: Hanover AB
Session Type: Concurrent Session 1

Description

This session will highlight recent progress in dynamic crosslinking strategies for hydrogels that enable tunable mechanics, adaptive remodeling, and improved cell–matrix interactions. Presentations will cover reversible chemistries, stimuli-responsive networks, and their applications in tissue engineering and drug delivery. The goal is to showcase how dynamic bonding enhances functional performance and biological integration of hydrogels.

Moderators:

Muhammad Rizwan
Assistant Professor, Biomedical Engineering
University of Texas Southwestern Medical Center

Chien-Chi Lin, PhD
Professor of Biomedical Engineering
Purdue University

Eben Alsberg, PhD
UIC Distinguished Professor
University of Illinois, Chicago

  • 1:30 PM. 20. Talk by Professor Cole DeForest, University of Washington Speakers Prof. Cole DeForest
  • 2:00 PM. 21. Leveraging tunable reactivity of intrinsic thioether bonds for on-demand degradation of PEG hydrogels with spatiotemporal control and semi-orthogonality.Tayler Hebner, Ph.D.1 1Purdue University
  • 2:15 PM. 22. Hyaluronic acid-based, double network hydrogels with tunable viscoelasticity for neural cell culture.Stephanie Seidlits, PhD1, Talia Sanazzaro, BS1, Sabrina Pietrosemoli Salazar, BS1, Ze Zhong Wang, PhD1, Neha Arvinth1, Arushi Nath1 1University of Texas at Austin
  • 2:30 PM. 23. Purely synthetic and fast-relaxing hydrogels for induced pluripotent stem cell culture.Nathan Dimmitt, PhD1, Chien-Chi Lin, PhD1 1Purdue University
  • 2:45 PM. 24. Dynamic covalent crosslinked hydrogels for the sustained delivery of bacteriophage to treat wound infections.Lucy Zhang1, Yung-Hao Lin1, Qingquan Chen1, Tejas Dharmaraj1, Cas de Leeuw2, Zhiwei Li1, Paul Bollyky1, Ovijit Chaudhuri1 1Stanford University, 2Radboud Universiteit
  • 3:00 PM. 25. Stimuli-Responsive Hydrogel to Improve Host Integration of Transplanted Corneal Endothelial Graft.Saad Asim1, Jodhbir Mehta, MBBS, FRCOphth, FRCS(Ed), FAMS, PhD (UK)2, Gary Peh, BSc, GradDip Reprod Sci, PhD3, Muhammad Rizwan, Ph.D.1 1UT Southwestern Medical Center, 2Singapore Eye Research Institute, 3Singapore Eye Research Institute,
  • 3:15 PM. 26. Extracellular vesicle–crosslinked supramolecular hydrogels with tunable network mechanics.Artemis Margaronis1, Santiago Correa1 1Columbia University

1E: Biomaterials and Nanotechnology for Cancer Modeling and Theranostics

Date: Wednesday, March 25, 2026
Time: 1:30 PM to 3:30 PM
Room: Hanover CDE
Session Type: Concurrent Session 1

Description

This symposium will highlight advances in biomaterial- and nanomaterial-based platforms that are transforming cancer research, diagnosis, and therapy. Biomaterials-based cancer models closely mimic the tumor microenvironment, enabling integration of multiple cell types, tunable matrices, patient-relevant treatments (e.g., radiation), and high-resolution mechanistic analysis to accelerate therapeutic development with improved efficacy and reduced toxicity. Complementing these approaches, nanomaterials are advancing cancer theranostics through multimodal imaging, remotely actuated non-invasive therapies, and innovative immunomodulatory strategies. Together, these technologies bridge physiologically relevant cancer models with next-generation nanomedicine to enhance therapeutic precision and clinical translation.

Moderators:

Dr. Ricardo Cruz-Acuna
Assistant Professor of Cancer Engineering
Columbia University Irving Medical Center

Daniel Harrington
Associate Professor
The University of Texas Health Science Center at Houston (UTHealth)

  • 1:30 PM. 27. Talk by Susan Thomas, Georgia Institute of Technology Speakers Dr. Susan Thomas
  • 2:00 PM. 28. Engineering Hydrogel Platforms to Investigate ECM-driven Tumor Formation and Therapy Resistance in Adenocarcinoma.Daniel Garcia, BS, MA1 1Columbia University
  • 2:15 PM. 29. 3D Droplet-Based Bioprinting for Tailorable Hydrogel Models of Head and Neck Cancer Tumor Microenvironments.Victoria Messuri1, Abbie Ha2, Daniel Harrington, PhD3 1Rice Uniersity, 2Rice University, 3The University of Texas Health Science Center at Houston
  • 2:30 PM. 30. Liver Extracellular Matrix Exposure Induces Dormancy Signatures in Colorectal Cancer Spheroids.Lucia Nash1, Anvitha Tharakesh1, Brinlee Goggans1, Scott Kopetz, M.D., Ph.D., F.A.C.P.2, Shreya Artha Raghavan, Associate Professor1 1Texas A&M University, 2University of Texas MD Anderson Cancer Center
  • 2:45 PM. 31. Photoacoustic Tracking of Nanoengineered NK Cells Using PLGA Nanoparticles in Combination with Radiotherapy.Brendan Barlow1, Tasneem Mukarrama2, Megan Purl2, Ana Sandoval-Castellanos, PhD2, Alexander LeBeau2, Arta Monjazeb, M.D., Ph.D.3, Sean Judge, M.D.2, Robert Canter, M.D.2, Jinhwan Kim, Ph.D.4 1University of California Davis, 2UC Davis, 3UC Davis Health, 4UC Davis Health, University of California, Davis
  • 3:00 PM. 32. Targeting Cell-Matrix Induced Chemoresistance With Regorafenib in a 3D Model of Osteosarcoma.Rameshwar Rao, MD PhD1, Michelle Huang, PhD2, Daiyao Zhang, BS2, Carla Huerta-López, PhD2, Christopher Long, BS2, Gisele Aviles Rodriguez2, Esther Mozipo, BS2, Sriya Sagi, MS1, Sarah Heilshorn, PhD2 1Seattle Children's Research Institute, 2Stanford University
  • 3:15 PM. 33. A 3D Osteosarcoma Model reveals Patient Heterogeneity in Drug Response and ECM Remodeling.Varsha Naga, B.S.1, Jeehee Lee, PhD1, Fan Yang, PhD1 1Stanford University

1F: Immunomodulatory Biomaterials 1

Date: Wednesday, March 25, 2026
Time: 1:30 PM to 3:30 PM
Room: Hanover FG
Session Type: Concurrent Session 1

Description

This session will highlight recent advances in the design and application of biomaterials that actively shape immune responses for therapeutic benefit. These biomaterials will span natural and synthetic materials engineered to modulate both innate and adaptive immunity in contexts including tissue repair, regenerative medicine, autoimmune disease, allergies, cancer immunotherapy, and transplantation. Topics will include, but are not limited to, the delivery of immunomodulators and imaging agents, antigen delivery, scaffolds for immunomodulation, microbiome modulation, combination therapies, cell-based therapies, and hydrogels for driving immune cell recruitment and polarization.

Moderators:

Dr. Brian Kwee
Assistant Professor
University of Delaware

Yaoying Wu
Assistant Professor
Biomedical and Chemical Engineering
Syracuse University

  • 1:30 PM. 34. Chirality-Driven Modulation of Macrophage Phenotype in Microporous Annealed Particle Scaffolds.Jeremy Thomas, B.S.1, Alejandra Suarez-Arnedo1, Yining Liu, PhD1, Pablo Cordero1, April Chavez Espinoza, B.S.1, Tatiana Segura, PhD1 1Duke University
  • 1:45 PM. 35. Macroporous Scaffolds For Fibroblastic Reticular Cell Delivery and T Cell Immune Regulation in Type 1 Diabetes.Leonor Teles, BS1, Quintin Spey, BS, MS1, Chris Li2, Lucy Ho, BS1, Ana Hernandez, BS3, Camillo Bechi Genzano, MD4, Remi Creusot, PhD4, Alice Tomei5 1University of Miami, 2Unviersity of Miami, 3University of Miami Miller School of Medicine, 4Columbia Center for Translational Immunology, 5University of Miami, Diabetes Research Institute
  • 2:00 PM. 36. Immune Checkpoint–Conjugated Granular Hydrogels Promote Treg-Mediated Control of Psoriatic Inflammation.Kenneth Kim1, Arielle D'Elia2, Lindsay Hager, MS2, Christopher Rodell, Ph.D.2 1Drexel University College of Medicine, 2Drexel University
  • 2:15 PM. 37. Localized versus Systemically Delivered Immunomodulation for Treatment of Psoriasis.Jennifer Simonovich, PhD1, Madeline Fuchs1, Sabrina Macias, PhD1, Arun Wanchoo, PhD1, Dorina Avram, PhD2, Gregory Hudalla, PhD1, Benjamin Keselowsky, PhD1 1University of Florida, 2Moffitt Cancer Center
  • 2:30 PM. 38. Commensal bacteria-derived sugar nanoparticles encapsulating glycosylated antigen for treatment of Inflammatory Bowel Disease.Zhenyu Wang, M.S.1, Nicole Crow1, Jamal Lewis, Ph.D.1, Jada Brown1, Amber Nguyen1, Tracy Chen1 1University of Florida
  • 2:45 PM. 39. Development of an Injectable Alginate Hydrogel for Enhanced MSC Viability and Targeted Delivery in Rat Intervertebral Disc Repair.Mohammadjafar Hashemi, PhD in chemical engineering1, Julia Victore1, Charlotte Chen1, Sade Williams Clayton1, Simon Tang1, Lori Setton1, Nathaniel Huebsch1 1Washington University in St. Louis
  • 3:00 PM. 40. Overcoming Regulatory T Cell Immunosuppression via Metal-Organic Framework Delivery.Mayayi Izzo1, Meredith Davis1, Ezra Cho1, Fanrui Sha, PhD2, Julian Magdalenski3, Omar Farha, PhD3, Michelle Teplensky, PhD1 1Boston University, 2AbbVie, 3Northwestern University
  • 3:15 PM. 41. Immune Activating Nanoparticles for Treatment of Glioblastoma.Alexander Kwiatkowski, PhD1, Jacob Schulman, BS1, Hayden Pagendarm, BS1, Mia Woodruff, BS1, John Wilson, PhD1 1Vanderbilt University

1G: Biomaterials & Surfaces: from Pioneering Medical Implants to Advanced Therapies.

Date: Wednesday, March 25, 2026
Time: 1:30 PM to 3:30 PM
Room: GH East AB
Session Type: Concurrent Session 1

Description

This symposium is dedicated to the innovative surface treatments of biostructured biomaterials, emphasizing their crucial role in medical technologies. Our goal is to create a dynamic forum for discussing cutting-edge research in surface treatments that enhance the efficacy of medical implants and advanced therapies.

Topics will explore pioneering techniques in hydroxyapatite and calcium phosphate coatings, as well as advanced surface texturing methods designed to improve osseointegration and biocompatiblity. We will discuss biologically modified surfaces that generate specific functionalities to stimulate or repress biological processes, adapting to the needs of various medical applications.

The forum will delve into the unique properties of biomaterials at the nanoscale, highlighting the potential for precise control over surface and structural characteristics at the submicron level. Key discussions will center on designing materials that mimic the extracellular matrix and developing surfaces with controlled activity capable of smart signaling when in contact with cells and biological fluids.

Attendees will gain insights into the latest medical implant surface treatment technologies and future advancements, including hydroxyapatite coatings and specialized abrasive techniques. Case studies will be presented for both dental and orthopedic implant applications, showcasing the impact of these innovative treatments on clinical outcomes.

Moderator:
Craig Rosenblum
President, Himed
Advisory Board Co-Chair
Department of Materials Science & Engineering
The Johns Hopkins University

  • 1:30 PM. 42. Optimizing Osteointegration: The Role of Calcium Phosphate Dual-Blasting in Implant Surface Texturing.Craig Rosenblum, HIMED Speakers Craig Rosenblum
  • 2:00 PM. 43. Photocatalytic and Antibacterial Performance of Mixed-Phase Titanium Oxides Formed by Different Surface Modification Techniques.Haden Johnson, PhD1, Parvin Fathi-Hafshejani, PhD2, Masoud Mahjouri-Samani, PhD2, Randall Williamson, PhD1, Mary Marquart, PhD1, Joel Bumgardner, PhD3, Amol Janorkar, PhD1, Michael Roach, PhD1 1University of Mississippi Medical Center, 2Auburn University, 3University of Memphis
  • 2:15 PM. 44. Distinct Ascorbate Conjugation Behavior on the Surface of Two Peptide Amphiphile Nanofiber Systems via Click Chemistry.Lu Yu, Ph.D.1, D. Gillis, MS1, Benjamin Ledford, PhD1, Robin Siletzky, BS1, Kyle Gray, BS2, Mark Karver, PhD2, Samuel Stupp, PhD2, Melina Kibbe, MD3, Nick Tsihlis, PhD1 1University of Virginia, 2Northwestern University, 3UTHealth Huston
  • 2:30 PM. 45. Patterned Surface Topographies Impact Dendritic Cell Maturation and Immune Phenotype.Ajay Chavda, B.S. Chemical Engineering1, Mohammad Asadi Tokmedash1, Jouha Min1 1University of Michigan
  • 2:45 PM. 46. Zwitterionic and Amphiphilic Copolymer Brush Surfaces to Control Macrophage Activation.Daniel Estrin1, Maelia Dziedzic1, Blayne Sarazin1, Daniel Schwartz1, Stephanie Bryant, PhD1 1Univeristy of Colorado - Boulder
  • 3:00 PM. 47. 3D-Printed Vascular Grafts with Surface Topography Enhance Vascular Function.Rao Fu, M.S.1, Anna Callaghan, BS1, Courtney Brady1, Jingyan Han, Ph.D.2, Yonghui Ding, Ph.D.1 1Worcester Polytechnic Institute, 2Boston University
  • 3:15 PM. 48. Biocompatible Fluorinated Polyphosphazene Catheter Coatings.Bryan Gregorits1, Myddelton Parker2, Chen Chen1, Isabel Martinez2, Ji Eun Park2, Chad Schmiedt2, Hitesh Handa, Ph.D.2, Harry Allcock1, Christopher Siedlecki3, Li-chong Xu3 1The Pennsylvania State University,, 2University of Georgia, 3Penn State College of Medicine

1H: Historically Marginalized Voices in Biomaterials Science and Engineering

Date: Wednesday, March 25, 2026
Time: 1:30 PM to 3:30 PM
Room: GH East CD
Session Type: Concurrent Session 1

Description

Moderator:

Dr. Riccardo Gottardi
Assistant Professor
Bioengineering and Biomaterials (Bio) lab
Children's Hospital of Philadelphia

Dr. Sarah Stabenfeldt
Knowledge Enterprise Fellow and President's Professor
Arizona State University

  • 1:30 PM. 49. Characterization of the GE11-599-siRNA Delivery System for a Locally Administered Co-Loaded Hydrogel to Treat Glioblastoma. Daphne Gomez Escudero1, Jessica Boulos, Bioengineering PhD1, Angela Alexander-Bryant, PhD Bioengineering1, Kay Russi1, Emalee Mann1, Aaron Anderson1 1Clemson University
  • 1:45 PM. 50. Endothelialized Sacrificial Alginate Microfibers for Rapid Graft Microvascularization.Firaol Midekssa1, Maggie Jewett1, Elizabeth Stanely1, Kaylin Hanna1, Vanini Pimpalwar1, Brendon M. Baker, PhD2 1University of Michigan, 2UNIVERSITY OF MICHIGAN- ANN ARBOR
  • 2:00 PM. 51. Tuning Granular Hydrogels Matrix Composition to Support Lymphatic Capillaries Formation in vitro and in vivo.Daniel Montes Pinzon1, Angela Taglione1, Ellie Johandes1, Salmady Ramos Valentin1, Donghyun Jeong1, Hsueh-Chia Chang1, Donny Hanjaya-Putra1 1University of Notre Dame
  • 2:15 PM. 52. A novel human-sized 3D in vitro cervical dysplasia model for testing ethyl cellulose–ethanol ablation.Gatha Adhikari1, Alina Sharma1, Kaitlin Fogg, Dr.2, Jenna Mueller, Dr.1 1University of Maryland, 2Oregon State University
  • 2:30 PM. 53. Senescence-Modulating Cryogel Scaffolds for Enhanced Osteogenesis Following Radiation Therapy.Peter Bertone1, Levi Olevsky1, Katherine Hixon1, Chelsea Bahney2, Maria Eduarda Torres Gouveia1 1Dartmouth College, 2University of California San Francisco
  • 2:45 PM. 54. Growth Factor-free Synthetic Hydrogel Enhances Marginal Corrective Dose of SC-Islets in the Gonadal Fat Pad of Diabetic Immune Deficient Mice.Sophia Kioulaphides, B.S., M.S.1, Angelica Torres1, Michael Hunckler, PhD1, Nathaniel Hogrebe, PhD2, Graham Barber, Research Technician1, Jeffrey Millman, Professor3, Esma Yolcu4, Haval Shirwan, Professor4, Andrés García, PhD1 1Georgia Institute of Technology, 2Washington University St. Louis, 3Washington University, St. Louis, 4University of Missouri
  • 3:00 PM. 55. Biodegradable Poly(caprolactone)/Poly(silyl fumarate) Shape Memory Scaffolds.Jenlyan Negron Hernandez1, Kaley Beach1, Paola Chavarria1, Melissa Grunlan, Ph.D.1 1Texas A&M University
  • 3:15 PM. 56. Engineering Estrogen: Granulosa Cell Encapsulation in Granular Hydrogels for Hormone Restoration Studies.Natasha Claxton, Ph.D.1, Arielle Efotte, M.S.1, Jay Huber, M.D., Ph.D.2, Lindsay Wells, M.D.3, Mykel Green, Ph.D.1 1Tulane University, 2The Fertility Institute of New Orleans, 3Audubon Fertility